These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Guidelines for the control of glycopeptide-resistant enterococci in hospitals. Cookson BD, Macrae MB, Barrett SP, Brown DF, Chadwick C, French GL, Hateley P, Hosein IK, Wade JJ, Combined Working Party of the Hospital Infection Society and Infection Control Nurses Association. J Hosp Infect; 2006 Jan; 62(1):6-21. PubMed ID: 16310890 [Abstract] [Full Text] [Related]
13. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. Aldeyab MA, Monnet DL, López-Lozano JM, Hughes CM, Scott MG, Kearney MP, Magee FA, McElnay JC. J Antimicrob Chemother; 2008 Sep; 62(3):593-600. PubMed ID: 18467307 [Abstract] [Full Text] [Related]
17. Politically incorrect: legislation must not mandate specific healthcare epidemiology and infection prevention and control practices. Fraser V, Murphy D, Brennan PJ, Frain J, Arias KM, Perl TM, Boards of Directors of APIC and SHEA. Infect Control Hosp Epidemiol; 2007 May; 28(5):594-5. PubMed ID: 17464921 [No Abstract] [Full Text] [Related]
18. Contamination, acquisition, and transmission of pathogens: implications for research and practice of infection control. Mundy LM. Infect Control Hosp Epidemiol; 2008 Jul; 29(7):590-2. PubMed ID: 18624665 [No Abstract] [Full Text] [Related]
19. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control. Gould IM. Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462 [Abstract] [Full Text] [Related]